PLoS ONE (Jan 2022)

Pooling saliva samples as an excellent option to increase the surveillance for SARS-CoV-2 when re-opening community settings.

  • Joaquín Moreno-Contreras,
  • Marco A Espinoza,
  • Carlos Sandoval-Jaime,
  • Marco A Cantú-Cuevas,
  • Daniel A Madrid-González,
  • Héctor Barón-Olivares,
  • Oscar D Ortiz-Orozco,
  • Asunción V Muñoz-Rangel,
  • Cecilia Guzmán-Rodríguez,
  • Manuel Hernández-de la Cruz,
  • César M Eroza-Osorio,
  • Carlos F Arias,
  • Susana López

DOI
https://doi.org/10.1371/journal.pone.0263114
Journal volume & issue
Vol. 17, no. 1
p. e0263114

Abstract

Read online

In many countries a second wave of infections caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has occurred, triggering a shortage of reagents needed for diagnosis and compromising the capacity of laboratory testing. There is an urgent need to develop methods to accelerate the diagnostic procedures. Pooling samples represents a strategy to overcome the shortage of reagents, since several samples can be tested using one reaction, significantly increasing the number and speed with which tests can be carried out. We have reported the feasibility to use a direct lysis procedure of saliva as source for RNA to SARS-CoV-2 genome detection by reverse transcription quantitative-PCR (RT-qPCR). Here, we show that the direct lysis of saliva pools, of either five or ten samples, does not compromise the detection of viral RNA. In addition, it is a sensitive, fast, and inexpensive method that can be used for massive screening, especially considering the proximity of the reincorporation of activities in universities, offices, and schools.